Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors

Detalhes bibliográficos
Autor(a) principal: Jablonka, Fernando
Data de Publicação: 2009
Outros Autores: Schindler, Fernanda, Lajolo, Paula Philbert, Pinczowski, Hélio, Fonseca, Fernando Luiz Affonso, Barbieri, Antônio, Massonetto, Luiz Henrique, Katto, Fábio Tadashi, Giglio, Auro del
Tipo de documento: Artigo
Idioma: eng
Título da fonte: São Paulo medical journal (Online)
Texto Completo: https://periodicosapm.emnuvens.com.br/spmj/article/view/1843
Resumo: CONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls.
id APM-1_f8f50acf1a8fcd6d4d8fc62cc1e51367
oai_identifier_str oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1843
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumorsDosagem sérica do N-telopeptídeo do colágeno tipo I (NTx) em pacientes com tumores sólidosNeoplasias ósseasCintilografiaValor preditivo dos testesFosfatase alcalinaColágeno tipo IBone neoplasmsRadionuclide imagingPredictive value of testsAlkaline phosphataseCollagen type ICONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls.CONTEXTO E OBJETIVO: Os N-telopeptídeos do colágeno tipo-I (NTx) elevam-se quando a reabsorção óssea está aumentada, devido a condições como osteoporose e metástase óssea. Sendo assim, temos por objetivo avaliar os níveis séricos de NTx em uma população heterogênea de pacientes com tumores sólidos. TIPO DE ESTUDO E LOCAL: Estudo transversal analítico com grupo controle, realizado em hospital público terciário. MÉTODOS: 19 pacientes sem história de câncer e 62 pacientes com tumores sólidos de vários tipos, encaminhados para estadiamento e investigação dos sintomas esqueléticos, foram avaliados pela técnica de ELISA (Enzyme Linked Immuno Sorbent Assay) quantitativa para a dosagem de NTx. Três especialistas leram todas as imagens ósseas. RESULTADOS: O nível de NTx encontrado em pacientes com câncer e metástase óssea, sem metástase óssea e sem diagnóstico de câncer foi 46,77 ± 2,58, 32,85 ± 2,05 e 22,32 ± 2,90, respectivamente (P < 0,0001). Não encontramos correlação entre o NTx, idade, sexo, história de dor óssea, tipo de tumor e níveis de fosfatase alcalina óssea. Encontramos correlação significativa entre os níveis de NTx e de Fosfatase Alcalina (r² = 0,08, P = 0,022). CONCLUSÃO: O NTx sérico é significativamente mais elevado em pacientes com tumores sólidos e metástases ósseas quando comparado com pacientes sem metástases ósseas e controles normais.São Paulo Medical JournalSão Paulo Medical Journal2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/1843São Paulo Medical Journal; Vol. 127 No. 1 (2009); 19-22São Paulo Medical Journal; v. 127 n. 1 (2009); 19-221806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/1843/1737https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessJablonka, FernandoSchindler, FernandaLajolo, Paula PhilbertPinczowski, HélioFonseca, Fernando Luiz AffonsoBarbieri, AntônioMassonetto, Luiz HenriqueKatto, Fábio TadashiGiglio, Auro del2023-09-15T20:12:14Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1843Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-09-15T20:12:14São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
Dosagem sérica do N-telopeptídeo do colágeno tipo I (NTx) em pacientes com tumores sólidos
title Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
spellingShingle Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
Jablonka, Fernando
Neoplasias ósseas
Cintilografia
Valor preditivo dos testes
Fosfatase alcalina
Colágeno tipo I
Bone neoplasms
Radionuclide imaging
Predictive value of tests
Alkaline phosphatase
Collagen type I
title_short Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
title_full Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
title_fullStr Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
title_full_unstemmed Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
title_sort Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
author Jablonka, Fernando
author_facet Jablonka, Fernando
Schindler, Fernanda
Lajolo, Paula Philbert
Pinczowski, Hélio
Fonseca, Fernando Luiz Affonso
Barbieri, Antônio
Massonetto, Luiz Henrique
Katto, Fábio Tadashi
Giglio, Auro del
author_role author
author2 Schindler, Fernanda
Lajolo, Paula Philbert
Pinczowski, Hélio
Fonseca, Fernando Luiz Affonso
Barbieri, Antônio
Massonetto, Luiz Henrique
Katto, Fábio Tadashi
Giglio, Auro del
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Jablonka, Fernando
Schindler, Fernanda
Lajolo, Paula Philbert
Pinczowski, Hélio
Fonseca, Fernando Luiz Affonso
Barbieri, Antônio
Massonetto, Luiz Henrique
Katto, Fábio Tadashi
Giglio, Auro del
dc.subject.por.fl_str_mv Neoplasias ósseas
Cintilografia
Valor preditivo dos testes
Fosfatase alcalina
Colágeno tipo I
Bone neoplasms
Radionuclide imaging
Predictive value of tests
Alkaline phosphatase
Collagen type I
topic Neoplasias ósseas
Cintilografia
Valor preditivo dos testes
Fosfatase alcalina
Colágeno tipo I
Bone neoplasms
Radionuclide imaging
Predictive value of tests
Alkaline phosphatase
Collagen type I
description CONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls.
publishDate 2009
dc.date.none.fl_str_mv 2009-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/1843
url https://periodicosapm.emnuvens.com.br/spmj/article/view/1843
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/1843/1737
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
dc.source.none.fl_str_mv São Paulo Medical Journal; Vol. 127 No. 1 (2009); 19-22
São Paulo Medical Journal; v. 127 n. 1 (2009); 19-22
1806-9460
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1825135068853567488